We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
| $978K | ﹤0.01% |
48,396
+3,158
| +7% | +$60.7K |
|
|
KCG
1927
DELISTED
KCG Holdings, Inc.
KCG
| $978K | ﹤0.01% |
54,868
-5,659
| -9% | -$84.1K |
|
1928
Phibro Animal Health
PAHC
$1.47B
| $977K | ﹤0.01% |
34,767
+11,111
| +47% | +$313K |
|
|
GNC
1929
DELISTED
GNC Holdings, Inc.
GNC
| $977K | ﹤0.01% |
132,724
+36,264
| +38% | +$312K |
|
|
HIFR
1930
DELISTED
InfraREIT, Inc.
HIFR
| $975K | ﹤0.01% |
54,181
+3,579
| +7% | +$61.2K |
|
1931
Xencor
XNCR
$1.5B
| $973K | ﹤0.01% |
40,673
+2,305
| +6% | +$55.5K |
|
|
AVX
1932
DELISTED
AVX Corporation
AVX
| $972K | ﹤0.01% |
59,335
+2,115
| +4% | +$33.8K |
|
|
ACET
1933
DELISTED
Aceto Corp
ACET
| $972K | ﹤0.01% |
61,484
+20,815
| +51% | +$355K |
|
|
FOLD
1934
DELISTED
Amicus Therapeutics
FOLD
| $968K | ﹤0.01% |
135,748
+4,958
| +4% | +$31.3K |
|
|
HAYN
1935
DELISTED
Haynes International, Inc.
HAYN
| $968K | ﹤0.01% |
25,394
+6,420
| +34% | +$257K |
|
|
CDR
1936
DELISTED
Cedar Realty Trust, Inc
CDR
| $967K | ﹤0.01% |
29,172
+7,133
| +32% | +$274K |
|
|
INFO
1937
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $965K | ﹤0.01% |
23,000
+4,400
| +24% | +$174K |
|
1938
Enanta Pharmaceuticals
ENTA
$366M
| $964K | ﹤0.01% |
31,305
+7,781
| +33% | +$242K |
|
1939
Kosmos Energy
KOS
$1.6B
| $962K | ﹤0.01% |
144,478
+10,555
| +8% | +$66.4K |
|
|
MTGE
1940
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $962K | ﹤0.01% |
57,461
+2,163
| +4% | +$35.4K |
|
1941
Q2 Holdings
QTWO
$3.8B
| $961K | ﹤0.01% |
27,572
+919
| +3% | +$30.6K |
|
|
RESI
1942
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $960K | ﹤0.01% |
62,952
+2,176
| +4% | +$28.4K |
|
|
LBAI
1943
DELISTED
Lakeland Bancorp Inc
LBAI
| $959K | ﹤0.01% |
48,932
+3,752
| +8% | +$72.4K |
|
1944
Titan International
TWI
$466M
| $958K | ﹤0.01% |
92,618
+27,510
| +42% | +$326K |
|
1945
Paylocity
PCTY
$7.38B
| $956K | ﹤0.01% |
24,735
-163
| -0.7% | -$5.67K |
|
1946
Medifast
MED
$109M
| $955K | ﹤0.01% |
21,534
+6,314
| +41% | +$272K |
|
1947
Weis Markets
WMK
$1.91B
| $953K | ﹤0.01% |
15,980
+398
| +3% | +$24.4K |
|
|
DERM
1948
DELISTED
Dermira, Inc.
DERM
| $951K | ﹤0.01% |
27,876
+1,297
| +5% | +$41.8K |
|
1949
Forestar Group
FOR
$1.44B
| $949K | ﹤0.01% |
69,519
+18,968
| +38% | +$248K |
|
1950
ICF International
ICFI
$1.46B
| $948K | ﹤0.01% |
22,953
+138
| +0.6% | +$6.68K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.